RZLT: Rezolute, Inc. Investigated for Securities Fraud; Block & Leviton Encourages Investors Who Have Lost Money to Contact the Firm

Core Viewpoint - Rezolute, Inc. has faced significant stock price decline of over 85% following the failure of its Phase 3 sunRIZE study in congenital hyperinsulinism, leading to an investigation by Block & Leviton for potential securities law violations [2][4]. Group 1: Company Performance - Shares of Rezolute fell over 85% on December 11 after the company announced that its Phase 3 sunRIZE study failed to meet its primary or key secondary endpoints [2]. - The company had previously made optimistic statements about the strength of earlier data and the outlook for the program, which may have misled investors [2]. Group 2: Legal Investigation - Block & Leviton is investigating whether Rezolute, Inc. committed securities law violations and may file an action to recover losses on behalf of affected investors [4]. - Investors who have lost money in their Rezolute investment are encouraged to contact Block & Leviton for potential recovery options [3][5]. Group 3: Whistleblower Information - Individuals with non-public information about Rezolute, Inc. are encouraged to assist in the investigation or file a report with the Securities Exchange Commission under the whistleblower program, which offers rewards of up to 30% of any successful recovery [6]. Group 4: Firm Reputation - Block & Leviton is recognized as a leading securities class action firm, having recovered billions of dollars for defrauded investors and representing many of the nation's top institutional investors [7].